Network News
Twelve scientists who conduct research at the German Cancer Research Center (DKFZ) or head joint bridge departments with the DKFZ have made it to the top in 2024: they are among the leading one percent of the world’s most cited researchers in their respective fields. Scientists whose work is particularly frequently cited by peers are […]
read more
VectorBuilder Wins BioIndustrial Innovation of the Year Award
Chicago, IL – NOVEMBER 19, 2024 – VectorBuilder, a global leader in gene delivery solutions, is excited to announce that it’s received the BioIndustrial Innovation of the Year award by the BioTech Breakthrough Awards. The recognition underscores VectorBuilder’s significant contributions to gene delivery technology through its Vector Design Studio, which has revolutionized the way researchers worldwide create and order custom […]
read more
Interdisciplinary Joint Project: New Bioengineering Approaches for the Automated Production of Complex Organoids
The Carl-Zeiss-Stiftung is funding Heidelberg-based research into molecular systems engineering with six million euros The reproducible and precise production of complex organoid models to simulate human organ malfunctions is the focus of an interdisciplinary research project at Heidelberg University. A research team from the life and engineering sciences is looking to combine the engineering of […]
read more
Selenium proteins as a possible new target for cancer research
An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM*. Proteins containing the element selenium […]
read more
AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
NORTH CHICAGO, Ill., Nov. 18, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian, fallopian tube or primary peritoneal cancer who have received one to three prior systemic treatment regimens. ELAHERE […]
read more
PHABIOC wins start-up prize
Company supported by Sparkasse Karlsruhe start-up consultancy receives award. The innovative start-up PHABIOC GmbH has won the prestigious Baden-Württemberg 2024 Founder Award, setting a new benchmark in biopharmaceutical research. More Information in German below. PHABIOC gewinnt Gründerpreis Von Gründungsberatung der Sparkasse Karlsruhe begleitetes Unternehmen ausgezeichnet. Das innovative Startup PHABIOC GmbH hat den renommierten Gründerpreis Baden-Württemberg […]
read more
Millions in federal funding: customized 3D printing for patients in oral and maxillofacial surgery
The German Federal Ministry of Education and Research (BMBF) is currently funding a project at the Department of Oral and Maxillofacial Surgery at Heidelberg University Hospital (UKHD) with around 1.2 million euros. The aim is to use 3D printing technology to produce individualized implants directly in the clinic, thus enabling faster, more efficient and more […]
read more
SPT Labtech brings the power of miniaturization to more genomics researchers with mosquito® Gen3
This new instrument delivers automated true positive displacement technology in an exceptionally compact footprint Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, has expanded its nanoliter liquid handling portfolio with the launch of mosquito Gen3. As the most compact and […]
read more
New Member: Welcome in our cluster to BioKryo GmbH
BioKryo is a biorepository focused on the storage of biological samples in temperatures ranging from -196°C in liquid nitrogen in cryotanks to -80°C, -20°C and 4°C in freezers. Their goal is to support biotechnology/pharmaceutical companies in their manufacturing process by providing a safe, redundant and qualified storage of their biological samples. Some examples of samples […]
read more
